logo
#

Latest news with #BioGrowing

BioGrowing Shines at Probiota Americas 2025, Leading Innovation in Probiotic Applications for Oral and Weight Management
BioGrowing Shines at Probiota Americas 2025, Leading Innovation in Probiotic Applications for Oral and Weight Management

Globe and Mail

time13-06-2025

  • Health
  • Globe and Mail

BioGrowing Shines at Probiota Americas 2025, Leading Innovation in Probiotic Applications for Oral and Weight Management

VANCOUVER - June 13, 2025 - BioGrowing, the Diamond Sponsor of Probiota Americas 2025, showcased groundbreaking advancements in oral health and weight management at the event. Through keynote presentations and panel discussions, the Chinese probiotic leader demonstrated its cutting-edge capabilities to the global scientific community. Innovative Oral Probiotic Solution Targets Billion-Dollar Market Dr. Zhanxi Hao, Vice President of the BioGrowing Research Institute, delivered a inspiring speech titled "Innovations In Oral Probiotics Research And Market Trends." He highlighted the rapid growth of the global oral healthcare market, projected to exceed $700 billion USD by 2030, with China's oral probiotic segment showing equally strong momentum. Probiotics, as core modulators of the oral microbiome, are driving oral health products to become a major market force due to their proven efficacy. As a pioneer in China's probiotic industry, BioGrowing has achieved technological leadership in oral probiotics through years of strain development: Lacticaseibacillus paracasei LPc-G110: The clinical research validating these oral probiotic strains was conducted at the Academic Centre for Dentistry Amsterdam (ACTA), ranked No. 1 in Europe and No. 2 globally in the QS World University Rankings for Dentistry. The trials demonstrated that BioGrowing's oral probiotic formulations effectively: Improve gingivitis, Reduce dental plaque formation, Decrease levels of harmful oral bacteria, Enhance oral micro-ecological stability. Ligilactobacillus salivarius LS-G60: Addresses halitosis at its source by inhibiting volatile sulfur compound (VSC) production. Clinically proven to outperform conventional treatments in combating halitosis. The Flora-Focus® Oral Health Fomula , developed based on these innovations, is now in industrial application. Concurrently launched, the novel OralBubble™ Probiotic Microbubble Lozenges deliver 10 Billion CFU per piece of clinically validated strains, offering a one-stop solution for 8 major oral concerns and meeting on-the-go oral health needs. Finished product testing confirms that the probiotic bubble tablets achieve VSC (volatile sulfur compound) inhibition rates of 98.76% at 16 hours and 98.09% at 24 hours post-administration, clinically validating their efficacy in delivering 24-hour oral freshness and halitosis reduction. Triple-Strain Consortium Addresses Global Obesity Challenge During the "Probiotics And Weight Management: Science or Myth?" roundtable discussion, BioGrowing's experts presented the company's latest research findings and scientific evidence supporting probiotic efficacy in weight management, exploring practical applications and potential in this field. Highlighting the public health crisis – global obesity rates surged from 36% (2000) towards 50% (2023) per the World Obesity Atlas 2025, with China designating 2025 as its "Weight Management Year" – BioGrowing introduced the Flora-Focus® Weight Management Fomula: Features a targeted triple-strain consortium: Lactobacillus gasseri LG-G12, Lactiplantibacillus plantarum ZJUF T17, and Lactiplantibacillus plantarum ZJUF T34. Mechanism: Enhances lipid metabolism efficiency, increases beige adipose tissue content, and inhibits high-fat diet-induced weight gain, while reducing hyperlipidemia risks associated with obesity. Provides a precise weight management solution for individuals with frequent dietary indiscretions, weight management goals, or dyslipidemia. Expanding Health Frontiers Through Scientific Rigor "From oral microbiome modulation to metabolic management, we are systematically building comprehensive probiotic health solutions," emphasized Dr. Hao. BioGrowing's relevant products have already secured international orders, marking the global reach of China's microbial technology innovation. Moving forward, BioGrowing remains committed to expanding health frontiers, delivering science-backed, safe, and effective health solutions to consumers worldwide. Media Contact Company Name: BIOGROWING CO.,LTD. Contact Person: Echo Sun Email: Send Email Country: China Website:

Southern Hemisphere Innovation Showcase: BioGrowing's AKKBG-001 Debuts at Naturally Good Expo
Southern Hemisphere Innovation Showcase: BioGrowing's AKKBG-001 Debuts at Naturally Good Expo

Zawya

time29-05-2025

  • Business
  • Zawya

Southern Hemisphere Innovation Showcase: BioGrowing's AKKBG-001 Debuts at Naturally Good Expo

SYDNEY, AUSTRALIA - Media OutReach Newswire - 29 May 2025 - BioGrowing, a leading Chinese probiotics innovator, marked its debut at the 2025 Naturally Good Expo in Sydney, showcasing its groundbreaking "Probiotic Family", including the star strain AKKBG-001. The event highlighted the company's commitment to advancing global health through cutting-edge research and multi-scenario applications of probiotics. Central of BioGrowing's exhibition was the unveiling of its independently developed AKKBG-001 strain. Demonstrated to support metabolic balance and immune enhancement, the strain's scalability in industrial production signals a milestone in China's probiotic R&D capabilities. During the expo,BioGrowing hosted a keynote session outlining global probiotic technology trends and introduced its core product lines addressing women's health, immune support, and oral health. BioGrowing's Flora-Focus® Women's Probiotic Series clinically validated formula combines three patented strains— Lactobacillus crispatus Lc-G22, Lactobacillus johnsonii LJ-G55, and Lacticaseibacillus rhamnosus Lr-G14—to inhibit fungal overgrowth and prevent vulvovaginal candidiasis (VVC), addressing growing regional health needs. Innovations such as the Flora-Focus® probiotic blend, OralBubble™ probiotic mirobubble lozenge, and OralFlash™ flash-melt probiotics drew significant attention. Company representatives also shared breakthroughs in proprietary strain screening, formulation technologies, and mechanistic research. "The true value of probiotics lies not only in solving health challenges but in driving sustainable industry progress," emphasized the Global Business Director. BioGrowing's science-driven approach, bolstered by collaborations with global academic institutions and eco-conscious production practices, continues to set benchmarks in the sector. Tailored to address Australia's prevalent gut health concerns, the Flora-Focus® range features clinically validated strains Lactobacillus acidophilus LA-G80 and Bifidobacterium animalis subsp. L actis BL-G101, proven to improve digestion, strengthen gut barriers, and stimulate beneficial fatty acid production. The patented YS1 strain further targets constipation relief with multi-layered microbiome support. Meanwhile, OralBubble™ and OralFlash™ redefine oral care through high-viability probiotics and flash-melt technology. With a "precision health" strategy, BioGrowing has developed a 9 category product matrix to meet diverse global needs, offering partners end-to-end solutions. Its expo booth emerged as a bridge connecting Chinese innovation with international markets, attracting distributors, health institutions, and media. "Australia represents a strategic foothold in our global expansion," stated the Global Business Director. "By integrating China's probiotic advancements into worldwide health ecosystems, we aim to empower every capsule with scientifically validated benefits." As BioGrowing continues to forge cross-border partnerships, its Sydney showcase underscores the rising influence of China's biotech sector in shaping the future of precision wellness. Hashtag: #BioGrowing The issuer is solely responsible for the content of this announcement. BioGrowing

Southern Hemisphere Innovation Showcase: BioGrowing's AKKBG-001 Debuts at Naturally Good Expo
Southern Hemisphere Innovation Showcase: BioGrowing's AKKBG-001 Debuts at Naturally Good Expo

The Sun

time29-05-2025

  • Business
  • The Sun

Southern Hemisphere Innovation Showcase: BioGrowing's AKKBG-001 Debuts at Naturally Good Expo

SYDNEY, AUSTRALIA - Media OutReach Newswire - 29 May 2025 - BioGrowing, a leading Chinese probiotics innovator, marked its debut at the 2025 Naturally Good Expo in Sydney, showcasing its groundbreaking 'Probiotic Family', including the star strain AKKBG-001. The event highlighted the company's commitment to advancing global health through cutting-edge research and multi-scenario applications of probiotics. Central of BioGrowing's exhibition was the unveiling of its independently developed AKKBG-001 strain. Demonstrated to support metabolic balance and immune enhancement, the strain's scalability in industrial production signals a milestone in China's probiotic R&D capabilities. During the expo,BioGrowing hosted a keynote session outlining global probiotic technology trends and introduced its core product lines addressing women's health, immune support, and oral health. BioGrowing's Flora-Focus® Women's Probiotic Series clinically validated formula combines three patented strains— Lactobacillus crispatus Lc-G22, Lactobacillus johnsonii LJ-G55, and Lacticaseibacillus rhamnosus Lr-G14—to inhibit fungal overgrowth and prevent vulvovaginal candidiasis (VVC), addressing growing regional health needs. Innovations such as the Flora-Focus® probiotic blend, OralBubble™ probiotic mirobubble lozenge, and OralFlash™ flash-melt probiotics drew significant attention. Company representatives also shared breakthroughs in proprietary strain screening, formulation technologies, and mechanistic research. 'The true value of probiotics lies not only in solving health challenges but in driving sustainable industry progress,' emphasized the Global Business Director. BioGrowing's science-driven approach, bolstered by collaborations with global academic institutions and eco-conscious production practices, continues to set benchmarks in the sector. Tailored to address Australia's prevalent gut health concerns, the Flora-Focus® range features clinically validated strains Lactobacillus acidophilus LA-G80 and Bifidobacterium animalis subsp. Lactis BL-G101, proven to improve digestion, strengthen gut barriers, and stimulate beneficial fatty acid production. The patented YS1 strain further targets constipation relief with multi-layered microbiome support. Meanwhile, OralBubble™ and OralFlash™ redefine oral care through high-viability probiotics and flash-melt technology. With a 'precision health' strategy, BioGrowing has developed a 9 category product matrix to meet diverse global needs, offering partners end-to-end solutions. Its expo booth emerged as a bridge connecting Chinese innovation with international markets, attracting distributors, health institutions, and media. 'Australia represents a strategic foothold in our global expansion,' stated the Global Business Director. 'By integrating China's probiotic advancements into worldwide health ecosystems, we aim to empower every capsule with scientifically validated benefits.' As BioGrowing continues to forge cross-border partnerships, its Sydney showcase underscores the rising influence of China's biotech sector in shaping the future of precision wellness.

Southern Hemisphere Innovation Showcase: BioGrowing's AKKBG-001 Debuts at Naturally Good Expo
Southern Hemisphere Innovation Showcase: BioGrowing's AKKBG-001 Debuts at Naturally Good Expo

Malay Mail

time29-05-2025

  • Business
  • Malay Mail

Southern Hemisphere Innovation Showcase: BioGrowing's AKKBG-001 Debuts at Naturally Good Expo

SYDNEY, AUSTRALIA - Media OutReach Newswire - 29 May 2025 - BioGrowing, a leading Chinese probiotics innovator, marked its debut at the 2025 Naturally Good Expo in Sydney, showcasing its groundbreaking "Probiotic Family", including the star strain AKKBG-001. The event highlighted the company's commitment to advancing global health through cutting-edge research and multi-scenario applications of of BioGrowing's exhibition was the unveiling of its independently developed AKKBG-001 strain. Demonstrated to support metabolic balance and immune enhancement, the strain's scalability in industrial production signals a milestone in China's probiotic R&D the expo,BioGrowing hosted a keynote session outlining global probiotic technology trends and introduced its core product lines addressing women's health, immune support, and oral health. BioGrowing's Flora-Focus® Women's Probiotic Series clinically validated formula combines three patented strains— Lactobacillus crispatus Lc-G22, Lactobacillus johnsonii LJ-G55, and Lacticaseibacillus rhamnosus Lr-G14—to inhibit fungal overgrowth and prevent vulvovaginal candidiasis (VVC), addressing growing regional health such as the Flora-Focus® probiotic blend, OralBubble™ probiotic mirobubble lozenge, and OralFlash™ flash-melt probiotics drew significant attention. Company representatives also shared breakthroughs in proprietary strain screening, formulation technologies, and mechanistic research."The true value of probiotics lies not only in solving health challenges but in driving sustainable industry progress," emphasized the Global Business Director. BioGrowing's science-driven approach, bolstered by collaborations with global academic institutions and eco-conscious production practices, continues to set benchmarks in the to address Australia's prevalent gut health concerns, the Flora-Focus® range features clinically validated strainsLA-G80 andBL-G101, proven to improve digestion, strengthen gut barriers, and stimulate beneficial fatty acid production. The patented YS1 strain further targets constipation relief with multi-layered microbiome support. Meanwhile, OralBubble™ and OralFlash™ redefine oral care through high-viability probiotics and flash-melt a "precision health" strategy, BioGrowing has developed a 9 category product matrix to meet diverse global needs, offering partners end-to-end solutions. Its expo booth emerged as a bridge connecting Chinese innovation with international markets, attracting distributors, health institutions, and media."Australia represents a strategic foothold in our global expansion," stated the Global Business Director. "By integrating China's probiotic advancements into worldwide health ecosystems, we aim to empower every capsule with scientifically validated benefits."As BioGrowing continues to forge cross-border partnerships, its Sydney showcase underscores the rising influence of China's biotech sector in shaping the future of precision #BioGrowing The issuer is solely responsible for the content of this announcement.

BioGrowing Shines at Natural Products Expo West, Leading a New Trend of Health with Innovative Probiotic Solutions
BioGrowing Shines at Natural Products Expo West, Leading a New Trend of Health with Innovative Probiotic Solutions

Yahoo

time09-03-2025

  • Health
  • Yahoo

BioGrowing Shines at Natural Products Expo West, Leading a New Trend of Health with Innovative Probiotic Solutions

Los Angeles, California--(Newsfile Corp. - March 8, 2025) - The highly anticipated Natural Products Expo West was grandly held from March 5th to 7th at the Anaheim Convention Center in Los Angeles, USA. As a top-tier event in the global natural and organic food sector, BioGrowing has been invited to participate for many years, showcasing its strength as a leading Chinese probiotic manufacturer to the world. To view an enhanced version of this graphic, please visit: Stepping into the BioGrowing booth, a fresh and natural style is immediately refreshing. The booth design is simple yet elegant, cleverly blending natural elements with a sense of technology, fully demonstrating BioGrowing's respect for nature and its persistent pursuit of health. At this exhibition, BioGrowing highlighted its Flora-Focus® multi-functional probiotic series, which covers 9 major areas including gut health, oral health, immune support, weight management, virginal health, skin health, glycemic management, blood pressure improvement, and H. pylori suppression. In addition, BioGrowing also launched 6 functional solid beverages/capsules, and OralBubble™ probiotic microbubble Lozenge, which continue the high-quality standards while comprehensively upgrading the formula, taste, and dosage form to meet the increasingly diverse health needs of consumers. To view an enhanced version of this graphic, please visit: During the exhibition, BioGrowing launched a highly anticipated viganal health solution. Clinical studies have shown that BioGrowing's independently developed Lactobacillus crispatus LC-G22 combined with clotrimazole can significantly reduce the symptoms of recurrent vulvovaginal candidiasis (VVC), effectively inhibit the proliferation of pathogenic bacteria, and has good tolerance and safety, thereby regulating the vaginal microecological balance and enhancing the vagina's self-cleaning ability. Combined with Lactobacillus johnsonii LJ-G55 and Lacticaseibacillus rhamnosus Lr-G14 to inhibit the growth of Candida in the female private parts, it can provide women with a more comprehensive and effective private care solution. To view an enhanced version of this graphic, please visit: Another highlight is the Flora-Focus® weight management product. This product contains a complex of strains such as Lactiplantibacillus plantarum Lp-G18, Lactobacillus gasseri LG-G12, Lactiplantibacillus plantarum ZJUF T17, and Lactiplantibacillus plantarum ZJUF T34, which can effectively improve lipid metabolism, reduce the risk of abnormal blood lipids, and achieve scientific weight management. Currently, this product has been successfully applied in the fields of nutritional supplements, dairy products, and functional foods. To view an enhanced version of this graphic, please visit: The new OralBubble™ probiotic microbubble Lozenge also attracted much attention. This product uses a sugar-free formula with 10 billion live bacteria, consisting of 3 clinically proven strains and 3 plant essences, and is supported by patents from 5 countries and 10 efficacy literatures (including 3 clinical studies), which can solve 8 major oral health problems such as bad breath, gingivitis, and dental plaque in one stop. To view an enhanced version of this graphic, please visit: Since its establishment in 2006, BioGrowing has been committed to the exploration and innovation of probiotics, and has published more than 100 scientific research papers at home and abroad, and applied for more than 70 invention patents and utility model patents. As the TOP3 immune health probiotic supplier and TOP5 digestive health probiotic supplier in the Asia-Pacific region, BioGrowing's products have been exported to more than 80 countries around the world, covering 22 of the 27 EU countries. To view an enhanced version of this graphic, please visit: This appearance at Natural Products Expo West is a powerful declaration by BioGrowing to the global health industry. In the future, BioGrowing will continue to adhere to the brand vision of "Global Leader in Probiotic Raw Materials," continuously explore and innovate, and bring more healthy, safe, and effective probiotic products to global consumers, working together to create a new future for human health. To view an enhanced version of this graphic, please visit: Media contactCompany Name: BIOGROWING CO., Echo SunEmail: cs@ +86 21 3920 5777Website: To view the source version of this press release, please visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store